ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • “Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.

  • “Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.

  • “Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • “Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.

  • “Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.

  • “Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.

  • “Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

 

 

 

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Dr Mar Villamiel, CIAL, CSIC-UAM, Spain

Dr. Mar Villamiel is the Director of CIAL (Institute of Food Science Research, CSIC-UAM) in Spain and leads the PREBIOIN research group focused on carbohydrate functionality and food bioactivity. With a PhD in Pharmacy from Complutense University of Madrid, she specializes in food technology, bioactive carbohydrates, and sustainable food preservation. Her innovative research centers on extracting and characterizing pectin and other functional ingredients from agri-food by-products. Dr. Villamiel has coordinated over 70 research projects and contracts, published 173 JCR articles (h-index: 46 WoS), co-authored 20 book chapters, and holds 7 patents. Her work has earned her national and international recognition, including being named among the Top 2% of Scientists worldwide by Stanford University. Passionate about science communication, she has presented at over 150 conferences and supervised more than 50 academic theses and internships globally. Her commitment to sustainability and technological advancement defines her as a leading force in food science research.

Publication Profile

Orcid

Education

Dr. Mar Villamiel completed her undergraduate degree in Pharmacy at Complutense University of Madrid in 1991 and earned her PhD in Pharmacy from the same institution in 1995. Her doctoral studies laid the groundwork for a highly interdisciplinary research career, incorporating analytical chemistry, food technology, and functional foods. Postdoctoral work in the Netherlands and professional exchanges in the UK expanded her knowledge in sustainable food preservation and the development of bioactive food compounds. Her deep educational foundation has supported her leadership in developing advanced methodologies in food science. Through ongoing academic collaborations and international stays, she continues to enhance her expertise and contribute to global education, mentoring students and researchers across Europe, Latin America, and beyond. Her academic path reflects a consistent trajectory of excellence, innovation, and dedication to research in food bioactivity and sustainable processing technologies. 🎓🔍📘🌍

Experience

Dr. Villamiel has over two decades of experience in food science research, beginning her career as a Tenured Scientist at CSIC (2000–2009). She later served as Deputy Director (2017–2019) and is currently the Director of CIAL since March 2021. She leads the PREBIOIN group, which explores carbohydrate functionality, pectin extraction, and sustainable food technologies. She has led 8 international projects, 34 industry contracts, and 72 total projects, often as Principal Investigator. She has published widely, mentored numerous PhDs (including international awardees), and edited prestigious scientific journals. Her collaborations span across institutions in Europe, Latin America, and Asia. She actively participates in EU regulatory panels and scientific committees and has received 10 research awards. Her interdisciplinary approach and leadership have made significant impacts in agri-food revalorization, food preservation, and nutritional functionality.

Awards and Honors

Dr. Mar Villamiel’s outstanding contributions have earned her numerous accolades, including 10 research awards and inclusion in the Stanford–Elsevier World’s Top 2% Scientists list in 2024. She has received five positive evaluations for six-year research periods, attesting to the sustained quality and impact of her work. Her research achievements include 7 patents (2 international), 173 JCR-indexed publications, and leadership of multi-million-euro research projects. She has served as an editor for major scientific journals and been an invited speaker at 17 international conferences. Her innovative methodologies in pectin extraction and bioactive compound analysis have been recognized with top conference awards, including First Prize at the Food Chemistry Conference (2023). She represents CSIC on platforms like the Biobased Industries Consortium and Food for Life. Her awards reflect her global influence, scientific leadership, and unwavering commitment to advancing sustainable food research.

Research Focus

Dr. Villamiel’s research focuses on the chemistry and functionality of carbohydrates, particularly pectins derived from agri-food by-products. She pioneers green extraction technologies such as ultrasound and subcritical water methods to obtain high-value bioactive compounds. Her work contributes significantly to sustainable food systems, enabling revalorization of food waste and enhancing nutritional profiles of food products. She leads multiple international collaborations and has developed in vitro digestion models to study carbohydrate behavior in the human gut. Her research addresses pressing challenges in food preservation, functional ingredient development, and biorefinery approaches for the food industry. With 173 publications, a high h-index (47 Scopus), and leadership in EU and Latin American projects, she is at the forefront of innovation in food science. Her contributions support public health, environmental sustainability, and industrial competitiveness through novel bioactive food solutions.

Publication Top Notes

Flours from popped grains: Physicochemical, thermal, rheological, and techno-functional properties

Use of natural low‐methoxyl pectin from sunflower by‐products for the formulation of low‐sucrose strawberry jams

Integral use of pectin-rich by-products in a biorefinery context: A holistic approach

Apple pomaces derived from mono-varietal Asturian ciders production are potential source of pectins with appealing functional properties

Application of sunflower pectin gels with low glycemic index in the coating of fresh strawberries stored in modified atmospheres

Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Published on by Research Hypothesis

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Prof Lina Vieira, ESTeSL/IPL, Portugal

Prof. Lina Vieira is a distinguished biomedical researcher and educator with a PhD in Biomedical Engineering and Biophysics from the University of Lisbon 🎓, awarded with Distinction and Honors 🏅. Her work primarily advances nuclear medicine, with a special focus on myocardial perfusion scintigraphy and SPECT imaging 🧠❤️. She holds a professorial position at the Lisbon School of Health Technology, actively contributing to both teaching and scientific innovation 📚🔬. Prof. Vieira has led several EU-funded projects, including PIANOFORTE, focusing on safe, optimized radiology for vulnerable populations 🤰📡. Her research blends technology, biophysics, and human-centered approaches like anxiety reduction and music therapy in imaging 🧘‍♀️🎵. An award-winning author and supervisor, she has trained numerous graduate students and remains a leading voice in radiological safety and optimization ⚛️. Her scientific rigor, innovation, and societal impact make her an ideal candidate for the Research Hypothesis Excellence Award 🏆🔍.

Publication Profile

Orcid

Education

Prof. Lina Vieira earned her PhD in Biomedical Engineering and Biophysics from the University of Lisbon in 2011 with Distinction and Honors 🎓🌟. Her thesis focused on optimizing myocardial perfusion studies using ECG-gated nuclear medicine imaging ❤️🧠. She also holds a Postgraduate Degree in Medical Physics and Biomedical Engineering (2005) and a Bachelor’s in Nuclear Medicine (2000) from the Lisbon School of Health Technology ⚛️📘. As part of her academic growth, she qualified through rigorous public examinations to become a Coordinating Professor in Nuclear Medicine within the Radiation Sciences and Biosignal Technologies Department at ESTeSL 👩‍🏫🧪. Her scholarly training is grounded in biophysics, imaging technology, and healthcare applications, forming a strong foundation for her future academic, research, and leadership achievements 🔬💡.

Experience

Prof. Vieira serves as a Coordinating Professor at the Lisbon School of Health Technology, leading Nuclear Medicine teaching and research initiatives 👩‍🏫🧠. She has been an integrated member of the Health & Technology Research Center since 2019, previously with the Institute of Biophysics and Biomedical Engineering at the University of Lisbon 🧬📊. Her work spans across modeling, signal processing, and human-centered diagnostic imaging, including participation in CIMOSM and GI-MOSM research centers 🧠⚙️. Notably, she coordinates the EU-funded PIANOFORTE project on safe radiology for pregnant patients 🤰📡, and leads innovative research on anxiety and music’s impact on image quality 🎵😌. Prof. Vieira is a mentor to many MSc students and has supervised several dissertations on SPECT imaging, Parkinson’s diagnostics, and PET education 📚📝. Her cross-disciplinary expertise makes her a leader in merging clinical practice with scientific excellence 🏥🔍.

Awards and Honors

Prof. Vieira has received multiple prestigious awards honoring her innovative research in nuclear medicine and imaging technology 🏅📡. She earned the Best Scientific Article Award from Saúde & Tecnologia in 2018, 2017, and 2015 for studies on technologist exposure, myocardial perfusion, and PET/CT in melanoma surveillance 🎖️📘. Her paper, “Value of a Lower Limb Immobilization Device for Optimization of SPECT/CT Image Fusion,” was named one of the Top 3 Papers by JNMT in 2015 and recognized at the 2016 Annual SNMMI Congress in San Diego 🇺🇸✨. These accolades reflect her commitment to high-impact, hypothesis-driven research that enhances clinical outcomes and patient safety 🧠❤️. With consistent recognition over the years, Prof. Vieira continues to lead innovations in nuclear medicine, both theoretically and practically 🔬📈.

Research Focus

Prof. Vieira’s research centers on optimizing nuclear medicine imaging, particularly myocardial perfusion scintigraphy (MPS), SPECT acquisition techniques, and patient-centered innovations in diagnostic imaging ❤️📸. She investigates the impact of psychophysiological variables, such as anxiety, on image quality and explores non-pharmacological interventions like music therapy to improve patient outcomes 🎶🧘‍♂️. A strong advocate for radiological safety, she spearheads projects like PIANOFORTE, which targets personalized radiology for pregnant patients 🤰⚛️. She also delves into educational methodologies, evaluating the effect of videos and social media in communicating ionizing radiation risks effectively 📲🧠. Her interdisciplinary focus combines engineering, patient psychology, radiological science, and public communication—making her work vital for improving both technical precision and patient experience in medical imaging 💡🩺. Her hypothesis-driven approach is rooted in measurable impacts, clinical relevance, and ethical responsibility 🔍📐.

Publication Top Notes

  • 📄 Myocardial Perfusion Scintigraphy: Impact of Anxiety on Image Quality (JPM, 2025 – submitted)

  • 📄 Potential Benefits of Social Media in Educating Healthcare Professionals and Students on Medical Imaging with Ionizing Radiation (Radiography Journal, 2025)

  • 📄 Effects of a Music-Based Intervention on Psychophysiological Outcomes of Patients Undergoing Imaging Procedures: A Systematic Review (Radiography Journal, 2024)

  • 📄 Effectiveness of Educational Videos on Patient’s Preparation for Diagnostic Procedures: Systematic Review and Meta-Analysis (Preventive Medicine Reports, 2022)

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Published on by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

 

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

 

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Joseph M Pappachan, Manchester Metropolitan University, United Kingdom

Prof. Dr. Joseph M. Pappachan is an internationally acclaimed endocrinologist and physician-scientist with profound contributions to metabolic and endocrine disorders. With over two decades of clinical, academic, and research experience, he currently serves at the Department of Endocrinology, Amrita Institute of Medical Sciences, India. His work bridges the gap between clinical practice and groundbreaking research, particularly in diabetes, obesity, metabolic syndrome, and endocrine hypertension. 📊 He has authored numerous high-impact publications and book chapters, and actively contributes to peer-reviewed journals as an editor and reviewer. Prof. Pappachan’s research is widely cited, reflecting his global influence in the field. 🌍 Known for his mentorship and academic leadership, he has trained many budding endocrinologists and researchers. His dedication to innovation and translational research has earned him multiple accolades and fellowships. 🧪 A dynamic scholar and clinician, Prof. Pappachan embodies excellence, integrity, and impact in the medical research community.

Publication Profile

Google Scholar

Education

Prof. Dr. Joseph M. Pappachan holds an MBBS degree from Government Medical College, Calicut, and completed his MD in Internal Medicine from Government Medical College, Trivandrum. 🏥 He further specialized in Endocrinology with a DM from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. 📘 In pursuit of global medical standards, he earned Membership of the Royal College of Physicians (MRCP) in the UK and became a Fellow of the Royal College (FRCP) and Fellow of the American College of Endocrinology (FACE). 🎖️ Prof. Pappachan has also undergone advanced training in endocrinology and diabetes in the United Kingdom and Europe, further honing his expertise in clinical research and metabolic diseases. 🌍 His commitment to lifelong learning is evident in his pursuit of continuing medical education and participation in international research fellowships, solidifying his position as an educator and research innovator in the medical sciences.

Experience

With over 20 years in clinical practice and academic research, Prof. Pappachan has served in leading institutions in India and the UK. 🏥 He is currently a Senior Consultant and Professor at the Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi. Previously, he held several academic positions in NHS hospitals and universities across the United Kingdom, where he actively participated in clinical trials and interdisciplinary research. 🌐 His professional journey includes experience in tertiary referral centers for complex endocrine and metabolic disorders. Prof. Pappachan is a sought-after speaker in national and international medical conferences and frequently leads CME programs for physicians. 🗣️ He also serves on the editorial boards of prominent journals and contributes significantly to peer-review processes. 🖋️ His extensive experience in patient care, medical education, and translational research makes him a respected authority in endocrinology worldwide.

Awards and Honors

Prof. Pappachan’s excellence in research has been recognized through numerous awards, fellowships, and international honors. 🏅 He has received the Fellowship of the Royal College of Physicians (FRCP), Fellowship of the American College of Endocrinology (FACE), and prestigious research grants for his work in metabolic disorders. 🎓 His research publications have garnered thousands of citations, and he ranks among the top Indian scientists in endocrinology. 📊 He has served as an expert panel member for international bodies and contributes to the development of clinical guidelines in diabetes and metabolic syndrome. 🌟 As an editorial board member and peer reviewer for several high-impact journals, his insight is valued across the medical research spectrum. 🧬 His outstanding contributions to patient care, research, and academic mentorship have earned him wide acclaim and nominations for top medical awards, making him a truly deserving candidate for the Best Researcher Award.

Research Focus

Prof. Pappachan’s research primarily centers on diabetes mellitus, obesity, metabolic syndrome, thyroid disorders, and hypertension, with a strong emphasis on the interplay between endocrine function and metabolic health. 🔍 His pioneering work investigates mechanisms of insulin resistance, neuroendocrine regulation, and cardiometabolic risk in various populations. His translational research explores clinical applications of novel diagnostic tools, therapeutic strategies, and biomarker discovery. 🧪 He has also examined sleep disorders and circadian rhythm disruptions in metabolic diseases and their implications for treatment outcomes. 🌙 His extensive publications focus on patient-centered interventions and the development of global clinical protocols. 📋 With multidisciplinary collaboration, Prof. Pappachan continues to advance understanding in precision medicine and evidence-based endocrinology, contributing significantly to the global discourse on metabolic and endocrine diseases. 🌐 His research is transformative, clinically relevant, and instrumental in shaping modern endocrine care.

Publication Top Notes

Omega-3 fatty acids: a comprehensive review of their role in health and disease

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

Diabetes mellitus and stroke: a clinical update

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study

Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes

Male obesity-related secondary hypogonadism–pathophysiology, clinical implications and managementMedicine and Health Sciences